Real-time enrollment status for this untreated follicular lymphoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:08 PM UTC
| NCT Number | NCT06549595 |
| Recruiting Status | Recruiting |
| Condition | Untreated Follicular Lymphoma |
| Phase | PHASE3 |
| Target Enrollment | 1,018 participants |
| Active Locations | 59 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT06549595 is currently recruiting participants. This phase3 study for untreated follicular lymphoma is actively seeking new participants at 59 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06549595 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 59 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06549595 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.